近来读到一篇报道[崔琦译.医药动态.陕西省医药管理局情报站.1985;1(3):10],说伦敦一家医院的微生物学教授要求对头孢菌素重新分类。他们认为,用所谓“第几代”的说法来区别不同的头孢菌素,具有两方面的弊病:一方面由于人们想现一代当然是前一代的衍生物(尽管两者结构截然不同),从而低估 Recently read a story [1], saying that a microbiology professor at a London hospital demanded a reclassification of cephalosporins. In their opinion, the distinction between different cephalosporins by the so-called “generations” has two drawbacks: on the one hand, since people want the present generation to be certainly derivatives of the previous generation (though the structures of the two are quite different) , So underestimated